Practice patterns evolution in thyrotropin suppressive therapy for low-risk differentiated thyroid cancer: A retrospective study from a tertiary endocrine center in Thailand

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20230701001

Enrollment

150

Registered

2023-07-01

Start date

2023-07-24

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low-risk differentiated thyroid cancer (DTC) Differentiated thyroid cancer, Low-risk thyroid cancer, Practice patterns evolution, Thyrotropin suppressive therapy, Thailand

Interventions

Adult Thai patients with low-risk DTC who had been regularly follow-up for at least 18 months between 2016-2022 at Theptarin Hospital

Treatment

Low-risk differentiated thyroid cancer (DTC)

Eligibility

Sex/Gender

All

Age

15 Years to 90 Years

Inclusion criteria

Inclusion criteria: Low-risk differentiated thyroid cancer (DTC) with follow-up at least 18 months at Theptarin Hospital

Exclusion criteria

Exclusion criteria: 1) Patients with not low-risk DTC 2) Incomplete medical data 3) Follow-up period less than 18 months were excluded.

Design outcomes

Primary

Measure	Time frame
Appropriate TSH targets (0.5-2.0 mIU/L) At the beginning of study Serum TSH levels	—

Secondary

Measure	Time frame
Associated factors with severe TSH suppression At the beginning of study Duration of practices among treating physicians	—

Countries

Thailand

Contacts

Public ContactYOTSAPON THEWJITCHAROEN

Theptarin Hospital

kamijoa@hotmail.com0892097154

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026